West Pharmaceutical Services, Inc. (WST)
416.58
+5.28
(+1.28%)
USD |
NYSE |
Nov 13, 16:00
416.58
0.00 (0.00%)
After-Hours: 19:59
West Pharmaceutical Services Enterprise Value : 28.56B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 28.56B |
| November 11, 2026 | 28.67B |
| November 10, 2026 | 28.65B |
| November 09, 2026 | 28.68B |
| November 06, 2026 | 27.76B |
| November 05, 2026 | 27.24B |
| November 04, 2026 | 28.38B |
| November 03, 2026 | 28.26B |
| November 02, 2026 | 28.32B |
| October 30, 2026 | 28.65B |
| October 29, 2026 | 28.93B |
| October 28, 2026 | 28.02B |
| October 27, 2026 | 27.65B |
| October 26, 2026 | 27.40B |
| October 23, 2026 | 27.22B |
| October 22, 2026 | 27.35B |
| October 21, 2026 | 27.31B |
| October 20, 2026 | 26.99B |
| October 19, 2026 | 26.65B |
| October 16, 2026 | 26.65B |
| October 15, 2026 | 26.58B |
| October 14, 2026 | 26.00B |
| October 13, 2026 | 25.80B |
| October 12, 2026 | 25.51B |
| October 09, 2026 | 25.40B |
| Date | Value |
|---|---|
| October 08, 2026 | 25.21B |
| October 07, 2026 | 25.43B |
| October 06, 2026 | 25.86B |
| October 05, 2026 | 26.15B |
| October 02, 2026 | 25.33B |
| October 01, 2026 | 25.33B |
| September 30, 2026 | 25.73B |
| September 29, 2026 | 26.40B |
| September 28, 2026 | 26.33B |
| September 25, 2026 | 25.96B |
| September 24, 2026 | 26.18B |
| September 23, 2026 | 26.34B |
| September 22, 2026 | 26.01B |
| September 21, 2026 | 25.35B |
| September 18, 2026 | 25.39B |
| September 17, 2026 | 25.69B |
| September 16, 2026 | 25.37B |
| September 15, 2026 | 25.58B |
| September 14, 2026 | 24.89B |
| September 11, 2026 | 24.26B |
| September 10, 2026 | 24.12B |
| September 09, 2026 | 23.60B |
| September 08, 2026 | 23.66B |
| September 04, 2026 | 23.81B |
| September 03, 2026 | 24.01B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.182B |
| Glaukos Corp. | 14.32B |
| The Cooper Cos., Inc. | 14.21B |
| Intuitive Surgical, Inc. | 148.53B |
| Becton, Dickinson & Co. | 74.08B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 214.00M |
| Revenue (Quarterly) | 874.40M |
| Total Expenses (Quarterly) | 660.40M |
| EPS Diluted (Quarterly) | 3.023 |
| Gross Profit Margin (Quarterly) | 39.84% |
| Profit Margin (Quarterly) | 24.47% |
| Earnings Yield | 2.14% |
| Operating Earnings Yield | 2.60% |
| Normalized Earnings Yield | 2.239 |